ID   DCLK1_HUMAN             Reviewed;         740 AA.
AC   O15075; B7Z3E9; Q5VZY8; Q5VZZ0; Q5VZZ1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   12-OCT-2022, entry version 205.
DE   RecName: Full=Serine/threonine-protein kinase DCLK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Doublecortin domain-containing protein 3A;
DE   AltName: Full=Doublecortin-like and CAM kinase-like 1;
DE   AltName: Full=Doublecortin-like kinase 1;
GN   Name=DCLK1; Synonyms=DCAMKL1, DCDC3A, KIAA0369;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=9747029; DOI=10.1007/s100380050063;
RA   Omori Y., Suzuki M., Ozaki K., Harada Y., Nakamura Y., Takahashi E.,
RA   Fujiwara T.;
RT   "Expression and chromosomal localization of KIAA0369, a putative kinase
RT   structurally related to Doublecortin.";
RL   J. Hum. Genet. 43:169-177(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Fetal brain;
RX   PubMed=10036192; DOI=10.1006/geno.1998.5718;
RA   Sossey-Alaoui K., Srivastava A.K.;
RT   "DCAMKL1, a brain-specific transmembrane protein on 13q12.3 that is similar
RT   to doublecortin (DCX).";
RL   Genomics 56:121-126(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=10051403; DOI=10.1006/geno.1998.5673;
RA   Matsumoto N., Pilz D.T., Ledbetter D.H.;
RT   "Genomic structure, chromosomal mapping, and expression pattern of human
RT   DCAMKL1 (KIAA0369), a homologue of DCX (XLIS).";
RL   Genomics 56:179-183(1999).
RN   [9]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal
RT   differential cellular gene expression in response to enterovirus 71
RT   infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   STRUCTURE BY NMR OF 51-156.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal DCX domain of human doublecortin-like
RT   kinase.";
RL   Submitted (NOV-2003) to the PDB data bank.
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-29; MET-46; GLN-93; PHE-291 AND
RP   HIS-292.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable kinase that may be involved in a calcium-signaling
CC       pathway controlling neuronal migration in the developing brain. May
CC       also participate in functions of the mature nervous system.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- INTERACTION:
CC       O15075; Q96M94: KLHL15; NbExp=2; IntAct=EBI-2684263, EBI-2510129;
CC       O15075-2; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-12324841, EBI-396137;
CC       O15075-2; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-12324841, EBI-2349927;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist. Type A (AS and AL) and
CC         type B (BS and BL) isoforms differ respectively by the presence or
CC         absence of the doublecortin domain. An alternative splicing occurring
CC         in 3' of the mRNA produces the long (L) instead of the short (S)
CC         isoforms.;
CC       Name=2; Synonyms=AL;
CC         IsoId=O15075-1; Sequence=Displayed;
CC       Name=1; Synonyms=AS;
CC         IsoId=O15075-2; Sequence=VSP_004907;
CC       Name=3; Synonyms=BS;
CC         IsoId=O15075-3; Sequence=VSP_004905, VSP_004906, VSP_004907;
CC       Name=4; Synonyms=BL;
CC         IsoId=O15075-4; Sequence=VSP_004905, VSP_004906;
CC   -!- TISSUE SPECIFICITY: In fetal tissues, highly expressed in brain,
CC       detectable in lung and liver, but not in kidney. In adult tissues,
CC       expressed ubiquitously in the brain, detectable in the heart, liver,
CC       spleen, thymus, prostate, testis, ovary, small intestine and colon. The
CC       type A isoforms seem to be expressed predominantly in fetal brain
CC       whereas type B isoforms are expressed abundantly in both fetal and
CC       adult brain. {ECO:0000269|PubMed:10051403}.
CC   -!- INDUCTION: Up-regulated in response to enterovirus 71 (EV71) infection
CC       (at protein level). {ECO:0000269|PubMed:16548883}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20824.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB002367; BAA20824.2; ALT_INIT; mRNA.
DR   EMBL; AL157760; CAH70167.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70170.1; -; Genomic_DNA.
DR   EMBL; AK295777; BAH12185.1; -; mRNA.
DR   EMBL; AL157760; CAH70168.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70261.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70262.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL157694; CAH70656.1; -; Genomic_DNA.
DR   EMBL; AL157760; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL157694; CAH70657.1; -; Genomic_DNA.
DR   EMBL; AL157760; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAI15720.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAI15721.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08550.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08551.1; -; Genomic_DNA.
DR   EMBL; BC152456; AAI52457.1; -; mRNA.
DR   CCDS; CCDS55895.1; -. [O15075-4]
DR   CCDS; CCDS73561.1; -. [O15075-3]
DR   CCDS; CCDS81762.1; -. [O15075-1]
DR   CCDS; CCDS9354.1; -. [O15075-2]
DR   RefSeq; NP_001182344.1; NM_001195415.1. [O15075-3]
DR   RefSeq; NP_001182345.1; NM_001195416.1. [O15075-4]
DR   RefSeq; NP_001317000.1; NM_001330071.1. [O15075-1]
DR   RefSeq; NP_001317001.1; NM_001330072.1. [O15075-1]
DR   RefSeq; NP_004725.1; NM_004734.4. [O15075-2]
DR   PDB; 1MFW; X-ray; 1.60 A; A=49-154.
DR   PDB; 1MG4; X-ray; 1.50 A; A=49-154.
DR   PDB; 1UF0; NMR; -; A=54-156.
DR   PDB; 5JZJ; X-ray; 1.71 A; A/B=372-649.
DR   PDB; 5JZN; X-ray; 2.85 A; A/B=372-649.
DR   PDB; 6KYQ; X-ray; 2.14 A; A/B=379-704.
DR   PDB; 6KYR; X-ray; 2.21 A; A/B=379-704.
DR   PDB; 7F3G; X-ray; 2.10 A; A/B=372-649.
DR   PDB; 7KX6; X-ray; 2.50 A; A/B=372-649.
DR   PDB; 7KX8; X-ray; 3.10 A; A/B=372-686.
DR   PDB; 7KXW; X-ray; 3.00 A; A/B=372-649.
DR   PDBsum; 1MFW; -.
DR   PDBsum; 1MG4; -.
DR   PDBsum; 1UF0; -.
DR   PDBsum; 5JZJ; -.
DR   PDBsum; 5JZN; -.
DR   PDBsum; 6KYQ; -.
DR   PDBsum; 6KYR; -.
DR   PDBsum; 7F3G; -.
DR   PDBsum; 7KX6; -.
DR   PDBsum; 7KX8; -.
DR   PDBsum; 7KXW; -.
DR   AlphaFoldDB; O15075; -.
DR   SMR; O15075; -.
DR   BioGRID; 114635; 91.
DR   IntAct; O15075; 37.
DR   MINT; O15075; -.
DR   STRING; 9606.ENSP00000255448; -.
DR   BindingDB; O15075; -.
DR   ChEMBL; CHEMBL5683; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; O15075; -.
DR   GuidetoPHARMACOLOGY; 2005; -.
DR   CarbonylDB; O15075; -.
DR   iPTMnet; O15075; -.
DR   PhosphoSitePlus; O15075; -.
DR   SwissPalm; O15075; -.
DR   BioMuta; DCLK1; -.
DR   EPD; O15075; -.
DR   jPOST; O15075; -.
DR   MassIVE; O15075; -.
DR   MaxQB; O15075; -.
DR   PaxDb; O15075; -.
DR   PeptideAtlas; O15075; -.
DR   PRIDE; O15075; -.
DR   ProteomicsDB; 48428; -. [O15075-1]
DR   ProteomicsDB; 48429; -. [O15075-2]
DR   ProteomicsDB; 48430; -. [O15075-3]
DR   ProteomicsDB; 48431; -. [O15075-4]
DR   Antibodypedia; 23046; 446 antibodies from 38 providers.
DR   DNASU; 9201; -.
DR   Ensembl; ENST00000255448.8; ENSP00000255448.4; ENSG00000133083.15. [O15075-2]
DR   Ensembl; ENST00000360631.8; ENSP00000353846.3; ENSG00000133083.15. [O15075-1]
DR   Ensembl; ENST00000379893.5; ENSP00000369223.1; ENSG00000133083.15. [O15075-4]
DR   Ensembl; ENST00000615680.4; ENSP00000484452.1; ENSG00000133083.15. [O15075-3]
DR   GeneID; 9201; -.
DR   KEGG; hsa:9201; -.
DR   MANE-Select; ENST00000360631.8; ENSP00000353846.3; NM_001330071.2; NP_001317000.1.
DR   UCSC; uc001uve.4; human. [O15075-1]
DR   CTD; 9201; -.
DR   DisGeNET; 9201; -.
DR   GeneCards; DCLK1; -.
DR   HGNC; HGNC:2700; DCLK1.
DR   HPA; ENSG00000133083; Tissue enhanced (brain).
DR   MIM; 604742; gene.
DR   neXtProt; NX_O15075; -.
DR   OpenTargets; ENSG00000133083; -.
DR   PharmGKB; PA162383325; -.
DR   VEuPathDB; HostDB:ENSG00000133083; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; KOG3757; Eukaryota.
DR   GeneTree; ENSGT00940000154956; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; O15075; -.
DR   OMA; CSKICVY; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; O15075; -.
DR   TreeFam; TF318770; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; O15075; -.
DR   SignaLink; O15075; -.
DR   BioGRID-ORCS; 9201; 12 hits in 1103 CRISPR screens.
DR   ChiTaRS; DCLK1; human.
DR   EvolutionaryTrace; O15075; -.
DR   GeneWiki; DCLK1; -.
DR   GenomeRNAi; 9201; -.
DR   Pharos; O15075; Tchem.
DR   PRO; PR:O15075; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; O15075; protein.
DR   Bgee; ENSG00000133083; Expressed in endothelial cell and 186 other tissues.
DR   ExpressionAtlas; O15075; baseline and differential.
DR   Genevisible; O15075; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0016197; P:endosomal transport; NAS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   Gene3D; 3.10.20.230; -; 2.
DR   InterPro; IPR003533; Doublecortin_dom.
DR   InterPro; IPR036572; Doublecortin_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF03607; DCX; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00537; DCX; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF89837; SSF89837; 2.
DR   PROSITE; PS50309; DC; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Developmental protein;
KW   Differentiation; Kinase; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..740
FT                   /note="Serine/threonine-protein kinase DCLK1"
FT                   /id="PRO_0000085919"
FT   DOMAIN          57..143
FT                   /note="Doublecortin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          186..269
FT                   /note="Doublecortin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          390..647
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          287..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          697..740
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        287..365
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        719..740
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        511
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         396..404
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         419
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         46
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08875"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         520
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         735
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   MOD_RES         738
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JLM8"
FT   VAR_SEQ         1..307
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9747029"
FT                   /id="VSP_004905"
FT   VAR_SEQ         308..313
FT                   /note="PASTSS -> MLELIE (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9747029"
FT                   /id="VSP_004906"
FT   VAR_SEQ         687..740
FT                   /note="TTALDKERQVFRRRRNQDVRSRYKAQPAPPELNSESEDYSPSSSETVRSPNS
FT                   PF -> LDHGFTIKRSGSLDYYQQPGMYWIRPPLLIRRGRFSDEDATRM (in
FT                   isoform 1 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10036192,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9205841, ECO:0000303|PubMed:9747029"
FT                   /id="VSP_004907"
FT   VARIANT         29
FT                   /note="G -> C (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045673"
FT   VARIANT         46
FT                   /note="T -> M (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045674"
FT   VARIANT         93
FT                   /note="R -> Q (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs1366698690)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045675"
FT   VARIANT         291
FT                   /note="S -> F (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045676"
FT   VARIANT         292
FT                   /note="R -> H (in dbSNP:rs56185003)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045677"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:1MFW"
FT   STRAND          56..63
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   STRAND          72..76
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   HELIX           84..95
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   HELIX           120..122
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   STRAND          128..135
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   HELIX           148..151
FT                   /evidence="ECO:0007829|PDB:1MG4"
FT   HELIX           384..389
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          390..398
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          400..409
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          415..422
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   TURN            423..425
FT                   /evidence="ECO:0007829|PDB:6KYQ"
FT   STRAND          427..429
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           436..440
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          451..456
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          458..466
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           473..480
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           485..504
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           514..516
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          517..521
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   STRAND          523..525
FT                   /evidence="ECO:0007829|PDB:7KX6"
FT   STRAND          527..531
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   TURN            551..553
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           556..560
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           568..582
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           596..603
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   TURN            610..615
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           618..627
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   TURN            632..634
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           638..643
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           645..647
FT                   /evidence="ECO:0007829|PDB:5JZJ"
FT   HELIX           662..668
FT                   /evidence="ECO:0007829|PDB:6KYQ"
FT   TURN            678..682
FT                   /evidence="ECO:0007829|PDB:6KYQ"
FT   HELIX           683..686
FT                   /evidence="ECO:0007829|PDB:6KYQ"
FT   HELIX           689..691
FT                   /evidence="ECO:0007829|PDB:6KYQ"
SQ   SEQUENCE   740 AA;  82224 MW;  D7B6D855099A315C CRC64;
     MSFGRDMELE HFDERDKAQR YSRGSRVNGL PSPTHSAHCS FYRTRTLQTL SSEKKAKKVR
     FYRNGDRYFK GIVYAISPDR FRSFEALLAD LTRTLSDNVN LPQGVRTIYT IDGLKKISSL
     DQLVEGESYV CGSIEPFKKL EYTKNVNPNW SVNVKTTSAS RAVSSLATAK GSPSEVRENK
     DFIRPKLVTI IRSGVKPRKA VRILLNKKTA HSFEQVLTDI TDAIKLDSGV VKRLYTLDGK
     QVMCLQDFFG DDDIFIACGP EKFRYQDDFL LDESECRVVK STSYTKIASS SRRSTTKSPG
     PSRRSKSPAS TSSVNGTPGS QLSTPRSGKS PSPSPTSPGS LRKQRSSQHG GSSTSLASTK
     VCSSMDENDG PGEEVSEEGF QIPATITERY KVGRTIGDGN FAVVKECVER STAREYALKI
     IKKSKCRGKE HMIQNEVSIL RRVKHPNIVL LIEEMDVPTE LYLVMELVKG GDLFDAITST
     NKYTERDASG MLYNLASAIK YLHSLNIVHR DIKPENLLVY EHQDGSKSLK LGDFGLATIV
     DGPLYTVCGT PTYVAPEIIA ETGYGLKVDI WAAGVITYIL LCGFPPFRGS GDDQEVLFDQ
     ILMGQVDFPS PYWDNVSDSA KELITMMLLV DVDQRFSAVQ VLEHPWVNDD GLPENEHQLS
     VAGKIKKHFN TGPKPNSTAA GVSVIATTAL DKERQVFRRR RNQDVRSRYK AQPAPPELNS
     ESEDYSPSSS ETVRSPNSPF
//
